Ampio Pharmaceuticals Issues Letter to Stockholders

Proposal to Authorize Reverse Stock Split has Been Approved ENGLEWOOD, Colo., Oct. 14, 2022 /PRNewswire/ — Ampio Pharmaceuticals, Inc. (NYSE American/OTC Pink: AMPE), today released the following letter to stockholders from its Chairman, Kevin Buchi, and Chief Executive Officer, Mike…

Click here to view original post